Murphy, SM, Lilleker, JB, Helliwell, P et al. (1 more author) (2016) The successful use of tocilizumab as third-line biologic therapy in a case of refractory anti-synthetase syndrome. Rheumatology, 55 (12). pp. 2277-2278. ISSN 1462-0324
Metadata
| Item Type: | Article |
|---|---|
| Authors/Creators: |
|
| Dates: |
|
| Institution: | The University of Leeds |
| Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) |
| Depositing User: | Symplectic Publications |
| Date Deposited: | 11 May 2018 11:04 |
| Last Modified: | 11 May 2018 11:04 |
| Status: | Published |
| Publisher: | Oxford University Press |
| Identification Number: | 10.1093/rheumatology/kew296 |
| Related URLs: | |
| Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:130629 |
Download not available
A full text copy of this item is not currently available from White Rose Research Online
CORE (COnnecting REpositories)
CORE (COnnecting REpositories)